Detalhe da pesquisa
1.
Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
Cytotherapy
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819367
2.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol
; 108(5): 437-445, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122325
3.
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Biol Blood Marrow Transplant
; 24(6): 1209-1215, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29474870
4.
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Br J Haematol
; 181(6): 782-790, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741758
5.
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Biol Blood Marrow Transplant
; 21(8): 1437-44, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25865648
6.
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
Br J Haematol
; 158(2): 174-185, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22640008
7.
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.
Front Immunol
; 13: 1074740, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601119
8.
Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population.
Clin Lymphoma Myeloma Leuk
; 21(7): 476-482, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33814336
9.
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 16(5): 639-46, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20005967
10.
Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian Cohort.
Clin Lymphoma Myeloma Leuk
; 20(7): e427-e436, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201130
11.
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center.
Clin Lymphoma Myeloma Leuk
; 19(12): 784-790, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31678079
12.
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Clin Lymphoma Myeloma Leuk
; 18(11): e481-e491, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100330
13.
Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemia.
Leuk Lymphoma
; 58(4): 909-915, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27561638
14.
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
Clin Lymphoma Myeloma Leuk
; 15(6): 341-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25656914
15.
Aurin tricarboxylic acid protects against red blood cell hemolysis in patients with paroxysmal nocturnal hemoglobinemia.
PLoS One
; 9(1): e87316, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24489894
16.
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.
Leuk Lymphoma
; 53(7): 1321-6, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22192245
17.
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).
Leuk Lymphoma
; 52(1): 34-41, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21133716